| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_84ded55cb61bd6cc9ff2179ce0d27b7d |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N43-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-415 |
| filingDate |
2012-04-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0b4623cc6c901928bd16ddacd9dc4c6b |
| publicationDate |
2012-10-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2012138809-A1 |
| titleOfInvention |
Heterocyclic compounds as kinase inhibitors |
| abstract |
The present invention relates to novel heterocyclic compounds of Formula (I) (Formula (I)) which act as inhibitors of kinase and are useful in methods of treating, preventing or inhibiting proliferative diseases including cancer. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103613591-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9447089-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9487515-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2672967-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2672967-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9096593-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11040027-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9624213-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9169250-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105384738-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9150570-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9663517-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9695169-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11337976-B2 |
| priorityDate |
2011-04-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |